Shanghai, China · Founded 2022 · Privately Held (backing)
Developer of green synthetic biological products. InnoGene BioTech is based in Shanghai, China and was founded in 2022. Its last reported valuation was $27 million in Dec 2022. It has raised $41.5 million.
Last reported valuation
$27.0M
Oct 2026
Priced at
—
Total raised
$41.5M
Last round
—
Team — not yet on record
No current team members for InnoGene BioTech are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of InnoGene BioTech with a free account
·Watch InnoGene BioTech: the Monday email on marks, rounds and moves
